Cargando…
Integrated Profiling Identifies CCNA2 as a Potential Biomarker of Immunotherapy in Breast Cancer
INTRODUCTION: Breast cancer is the main reason for cancer-related deaths in women and the most common malignant cancer among women. In recent years, immunosuppressive factors have become a new type of treatment for cancer. However, there are no effective biomarkers for breast cancer immunotherapy. T...
Autores principales: | Wang, Yichao, Zhong, Qianyi, Li, Zhaoyun, Lin, Zhu, Chen, Hanjun, Wang, Pan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8043851/ https://www.ncbi.nlm.nih.gov/pubmed/33859479 http://dx.doi.org/10.2147/OTT.S296373 |
Ejemplares similares
-
CCNA
por: Valentine, Michael, et al.
Publicado: (2008) -
CCNA voice
por: Bateman, David, et al.
Publicado: (2009) -
CCNA2 Is a Prognostic Biomarker for ER+ Breast Cancer and Tamoxifen Resistance
por: Gao, Tian, et al.
Publicado: (2014) -
Integrated Profiling Identifies PLOD3 as a Potential Prognostic and Immunotherapy Relevant Biomarker in Colorectal Cancer
por: Shi, Junhong, et al.
Publicado: (2021) -
CCNA practical studies
por: Heap, Gary, et al.
Publicado: (2002)